Lianping XING - Webster NY, US Brendan F. BOYCE - Pittsford NY, US Edward M. SCHWARZ - Rochester NY, US
Assignee:
UNIVERSITY OF ROCHESTER - Rochester NY
International Classification:
A61K 39/395 A61K 38/16 A61K 31/7088
US Classification:
4241581, 514 12, 514 44 R, 514 44 A
Abstract:
The present invention is directed to methods of treating an inflammatory condition in a patient. This method includes providing a therapeutic agent that is a vascular endothelial growth factor receptor-3 (VEGFR-3) agonist or a nucleic acid molecule encoding a VEGFR-3 agonist. The present invention is further directed to pharmaceutical compositions and therapeutic systems for treating an inflammatory condition.
Methods And Compositions For Treating Inflammatory Conditions
The present invention is directed to methods of treating an inflammatory condition in a patient. This method includes providing a therapeutic agent that is a vascular endothelial growth factor receptor-3 (VEGFR-3) agonist or a nucleic acid molecule encoding a VEGFR-3 agonist. The present invention is further directed to pharmaceutical compositions and therapeutic systems for treating an inflammatory condition.
Phosphonate-Chloroquine Conjugates And Methods Using Same
- Rochester NY, US Brendan Boyce - Woodbury NY, US Lifeng Xiao - Rochester NY, US Frank H. Ebetino - Venice FL, US
International Classification:
A61K 31/4706 A61K 47/54
Abstract:
The present invention provides compositions and methods for providing controllable local delivery of a conjugate of chloroquine (CQ) and a bisphosphonate to treat diseases characterized by abnormal bone metabolism. In certain embodiments, the invention is used as a treatment for a subject with diseases and disorders characterized by bone loss.
- Rochester NY, US Robert Boeckman - Honeoye Falls NY, US Lianping Xing - Webster NY, US Lifeng Xiao - Rochester NY, US Brendan Boyce - Woodbury NY, US
International Classification:
A61K 47/54 A61K 31/69 A61P 19/00 A61P 35/00
Abstract:
The present invention provides compositions and methods for providing controllable local delivery of a conjugate of bortezomib (Btz) and a bisphosphonate to promote bone formation. In certain embodiments, the invention is used as a treatment for a subject with diseases and disorders characterized by bone loss.
Name / Title
Company / Classification
Phones & Addresses
Brendan Boyce Treasurer
Biological Stain Commission Professional Organization Business Consulting Services
575 Elmwood Ave, Rochester, NY 14620 PO Box 626, Rochester, NY 14642 601 Elmwood Ave #626, Rochester, NY 14642 5852752751
Brendan F. Boyce Clinical Pathology
Univ Ortho of Rochestr PC Medical Doctor's Office
601 Elmwood Ave, Rochester, NY 14642
Brendan Boyce Medical Doctor
Brendan F Boyce Professional Organizations
601 Elmwood Ave, Rochester, NY 14642
Medicine Doctors
Dr. Brendan F Boyce, Rochester NY - MD (Doctor of Medicine)
University Of Rochester Medical Center Pathology 601 Elmwood Ave, Rochester, NY 14642 5852763927 (phone), 5852733003 (fax)
Education:
Medical School Univ of Glasgow, Fac of Med, Glasgow, Scotland (803 05 Pr 1/71) Graduated: 1972
Languages:
English
Description:
Dr. Boyce graduated from the Univ of Glasgow, Fac of Med, Glasgow, Scotland (803 05 Pr 1/71) in 1972. He works in Rochester, NY and specializes in Anatomic Pathology & Clinical Pathology.
Legrand/ Ortronics New London, CT Aug 2010 to Apr 2011 Product SpecialistOFS a Furikawa company Avon, CT Jan 2007 to Aug 2010 Optical TechnicianAPT Residential Services Bridgeport, CT Jul 2006 to Dec 2006 Business Office CoordinatorAmtec Rocky Hill, CT Apr 2004 to Sep 2005Rocky Mountain Fiber Plus Newington, CT Feb 2001 to Nov 2003
Education:
Tunxis Community Aug 1999 to Dec 2000 BA in design